Literature DB >> 8385758

Electrophysiological effects of 25-35 amyloid-beta-protein on guinea-pig lateral septal neurons.

B Carette1, P Poulain, A Delacourte.   

Abstract

The amyloid-beta-protein (A beta P) is the major component of the amyloid deposition which characterizes Alzheimer's disease. We have investigated the effects of 25-35 A beta P, the biologically active part of A beta P, on 35 lateral septal neurons in slices of guinea-pig brain during intracellular recording. Bath application of 25-35 A beta P (10(-6) M) caused transient or long-lasting membrane depolarizations in 15 neurons. These effects were not obtained with a 25-35 A beta P peptide synthetized at random. In 7 other neurons, in control medium or in presence of tetrodotoxin, 25-35 A beta P increased the amplitude of excitatory responses produced by local iontophoretic applications of glutamate and NMDA. The data demonstrate for the first time the excitatory effects of 25-35 A beta P on central neurons, effects which may be involved in the mechanisms of neuronal death in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385758     DOI: 10.1016/0304-3940(93)90059-t

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Amyloid beta peptide membrane perturbation is the basis for its biological effects.

Authors:  J N Kanfer; G Sorrentino; D S Sitar
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

2.  Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo.

Authors:  V V Trubetskaya; M Yu Stepanichev; M V Onufriev; N A Lazareva; V A Markevich; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2003-02

3.  A femtomolar-acting neuroprotective peptide.

Authors:  D E Brenneman; I Gozes
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 4.  Calcium signaling and amyloid toxicity in Alzheimer disease.

Authors:  Angelo Demuro; Ian Parker; Grace E Stutzmann
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

Review 5.  The toxicity in vitro of beta-amyloid protein.

Authors:  L L Iversen; R J Mortishire-Smith; S J Pollack; M S Shearman
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

Review 6.  Mechanisms of amyloid beta protein-induced modification in ion transport systems: implications for neurodegenerative diseases.

Authors:  J I Kourie
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

7.  Effects of beta-amyloid-(25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor.

Authors:  R F Cowburn; B Wiehager; E Trief; M Li-Li; E Sundström
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

8.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 9.  Aβ toxicity in Alzheimer's disease.

Authors:  Virve Cavallucci; Marcello D'Amelio; Francesco Cecconi
Journal:  Mol Neurobiol       Date:  2012-03-14       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.